Merck Signs Two Oncology Collaborations with Seattle Genetics
By Michelle Liu
Pharma Deals Review: Vol 2020 Issue 9 (Table of Contents)
Published: 21 Sep-2020
DOI: 10.3833/pdr.v2020.i9.2563 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Cementing its interest in antibody-drug conjugate technology, Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS